Their primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels with a low risk of hypoglycaemia when used alone (though risk increases when combined with insulin or sulfonylureas) Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake These combined effects result in improved glycaemic control for people with diabetes and significant weight loss
Mitochondrial Complex I Defect Induces ROS Release and Degeneration in Trabecular Meshwork Cells of POAG Patients: Protection by Antioxidants
Consequently, studying PTMs in the context of ferroptosis holds promising prospects for the development of drugs with high specificity, selectivity, and low toxicity for the treatment of various diseases and cancers in the future
LSECs make up around 3% of liver cell volume, and in mice that did not have LSEC receptors, there were no benefits to taking semaglutide (even after losing 20% of their body weight)
